Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13
Closed -$1.03K 504
2025
Q2
$1.03K Hold
13
﹤0.01% 443
2025
Q1
$1.17K Buy
+13
New +$1.21K ﹤0.01% 413
2023
Q4
Sell
-6,766
Closed -$697K 452
2023
Q3
$697K Sell
6,766
-8
-0.1% -$862 0.42% 87
2023
Q2
$782K Sell
6,774
-1,303
-16% -$148K 0.46% 73
2023
Q1
$859K Sell
8,077
-3
-0% -$324 0.47% 73
2022
Q4
$896K Buy
8,080
+542
+7% +$55.4K 0.47% 23
2022
Q3
$649K Sell
7,538
-1,191
-14% -$106K 0.26% 142
2022
Q2
$796K Buy
+8,729
New +$774K 0.3% 94
2020
Q3
Sell
-174
Closed -$13K 392
2020
Q2
$13K Hold
174
0.01% 415
2020
Q1
$13K Buy
+174
New +$13.7K 0.01% 369
2019
Q4
Sell
-511
Closed -$41K 490
2019
Q3
$41K Buy
+511
New +$41K 0.01% 293

Other funds holding MRK

Virtus ETF Advisers's MRK Position: Q3 2025 in Review

Virtus ETF Advisers sold out of Merck (MRK) in Q3 2025, closing a stake of 13 shares — an estimated $1.03K sold.

Virtus ETF Advisers first reported a position in MRK in Q3 2019 and held it in 11 quarters. The position peaked at $896K in Q4 2022. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Virtus ETF Advisers reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 13 Merck shares in Q3 2025, an estimated $1.03K.
  • Virtus ETF Advisers first reported a position in Merck in Q3 2019 and held it in 11 quarters.
  • Virtus ETF Advisers's Merck position peaked at $896K in Q4 2022.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Virtus ETF Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.